Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.
In United StatesThis study is recruiting in the United States, in France, in Belgium, .... It is testing KarXT for Schizophrenia.
In United States
This study is recruiting in the United States. It is testing KYN-5356 for schizophrenia.
In United StatesThis study is recruiting in the United States, in Australia, in Canada, .... It is testing Safety and Efficacy of KarXT + KarX-EC for Schizophrenia.
In United StatesThis study is recruiting in the United States. It focuses on Schizophrenia.
In United StatesThis study is recruiting in the United States. It is testing DT-101 for depression.
In United StatesThis study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing DT-101 for depression.
In United StatesThis study is recruiting in the United States. It focuses on adults with tardive dyskinesia who remain symptomatic while receiving or after stopping a VMAT2 inhibitor.
In United StatesThis study is recruiting in the United States. It focuses on ADHD.
In United StatesThis study is recruiting in the United States, in France, in Argentina, .... It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.
In United StatesThis study is recruiting in the United States, in Brazil, in Hungary, .... It is testing esketamine for depression.
In United StatesThis study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.